Bismuth Subsalicylate
Product Images NDC 70166-059

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Bismuth Subsalicylate (NDC 70166-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lohxa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display (Bismuthcup 20191219 210715)

This is a description of an oral suspension medication containing Bismuth Subsalicylate. Each 15ml of the product contains 262mg of Bismuth Subsalicylate. It is for oral use only and should be shaken well before use. The product is repackaged by Lohxa and is intended for institutional use. The USP Controlled Room Temperature is recommended, and the insert should be consulted for dosage and administration guidance.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.